Unlisted Deals:
×

New Era Alkaloids and Export Annual Report and Financials

Last Traded Price 10.00 + 0.00 %

New Era Alkaloids and Export Limited (New Era Alkaloids) Return Comparision with Primex 40 Index

Periods 1 Week 1 Month 3 Months 6 Months 1 Year 3 Years All Time
Primex-40
New Era Alkaloids and Export Limited

New Era Alkaloids & Exports Limited Standalone Balance Sheet (Rs in Lakhs)

Particulars

31-03-2024

31-03-2023

Non-current assets

 

 

Property, plant and equipment

0.04

0.06

Investments

212.98

1180.17

Loans and advances

535.56

456.74

Deferred tax assets (net)

26.49

-

Other non-current assets

55.27

55.27

Current assets

 

 

Trade receivables

-

9.82

Cash and cash equivalents

3.99

3.39

Current Tax Assets

1.31

-

Other Current Assets

27.04

26.99

Total assets

862.69

1733.23

Equity

 

 

Equity share capital

328.44

328.44

Other equity

474.40

477.93

Non-current liabilities

 

 

Borrowings

-

493.61

Deferred tax liabilities (net)

-

96.64

Current liabilities

 

 

Borrowings

-

335.00

Total outstanding dues of creditors other

than micro enterprises and small enterprises

0.31

-

Other financial liabilities

0.08

1.15

Current tax liabilities (net)

58.87

-

Provisions

0.60

0.47

Total equity and liabilities

862.69

1733.23

New Era Alkaloids & Exports Limited Standalone Profit & Loss Statement (Rs in Lakhs)

Particulars

31-03-2024

31-03-2023

Revenue from Operation

-

8.00

Other Income

39.38

8.12

Total Income

 

 

Expenses

 

 

Employee Benefits Expenses

2.96

2.87

Finance Costs

0.01

0.01

Depreciation and Amortization Expenses

0.02

0.03

Other Expenses

3.23

114.32

Total Expenses

6.22

117.32

Profit/Loss before tax

33.17

-109.11

Current tax

58.87

-

Deferred tax

0.01

0.01

Profit/Loss for the Period

-25.72

-109.12

Other comprehensive income

 

 

Items that will not be reclassified to profit and loss

-100.96

294.59

Income tax relating to items that will not be reclassified

to profit or loss

123.14

-94.82

Total comprehensive income for the year

-3.54

90.65

Paid-up Share Capital

328.44

328.44

Earnings per Equity Share

-0.78

-3.32

New Era Alkaloids & Exports Limited Standalone Cash Flow Statement (Rs in Lakhs)

Particulars

31-03-2024

31-03-2023

Cash Flow From Operating Activities

 

 

Profit/(loss) before tax after exceptional items

33.17

-109.11

Adjustments:

 

 

Depreciation

0.02

0.03

Interest Charged to P & L A/c

0.01

0.01

Interest received from parties

-39.35

-

Irrecoverable balances written off

0.00

110.42

Operating Profit before Working Capital Changes

-6.16

1.35

Adjustments:

 

 

Decrease/(Increase) in Trade & Other receivables

-69.57

339.61

Increase/(Decrease) in Payables

58.24

-6.30

Cash generated from Operations

-17.49

334.66

Direct Taxes Paid

58.87

-

Net Cash from Operating Activity

-76.36

334.66

Cash Flow From Investing Activities

 

 

Proceeds from sale of shares

866.23

-

Net Cash from Investing Activity

866.23

-

Cash Flow From Financing Activities

 

 

Proceeds from Unsecured Loans ( Net)

-828.61

-334.00

Interest Paid

-0.01

-0.01

Interest received from parties

39.35

-

Net Cash From Financing Activities

-789.27

-334.01

Increase in cash and cash equivalents

0.60

0.65

Cash and cash equivalents as at the beginning of year

3.39

2.74

Cash and cash equivalents as at end of the year

3.99

3.39

Here is a summary of the Cash Flow Statement for the years 2024 and 2023:

Operating Activities:

In FY 2024, the company posted a profit before tax of ₹33.17 lakhs, recovering from a ₹109.11 lakhs loss in FY 2023. However, due to increased receivables and tax payments, it reported a net cash outflow of ₹76.36 lakhs, compared to an inflow of ₹334.66 lakhs in FY 2023, which had benefited from one-time write-offs and better working capital position.

Investing Activities:

The company reported a substantial inflow of ₹866.23 lakhs in FY 2024 from the sale of shares, indicating a divestment of investments or strategic assets. This was absent in FY 2023, where no investing activities were reported. This sharp inflow highlights a deliberate strategy to liquidate investments to support liquidity or other financial needs.

Financing Activities:

In FY 2024, net outflows from financing activities stood at ₹789.27 lakhs, primarily due to the repayment of unsecured loans amounting to ₹828.61 lakhs. A small interest expense of ₹0.01 lakhs was recorded, and an interest income of ₹39.35 lakhs from parties was included in this section. In FY 2023, a similar pattern was observed, with unsecured loans of ₹334 lakhs being repaid, resulting in a net cash outflow of ₹334.01 lakhs. This consistent trend suggests the company is gradually reducing its debt burden.

Net Cash Position:

Despite negative cash flows from operations and financing activities in FY 2024, the large investing inflow led to a modest net increase of ₹0.60 lakhs in cash and cash equivalents, ending the year with a closing balance of ₹3.99 lakhs, up from ₹3.39 lakhs in FY 2023. In the previous year, the net cash increase was ₹0.65 lakhs, indicating stable but low cash reserves.

Financial Ratios of New Era Alkaloids & Exports Limited

Particulars

2024

2023

Current ratio

0.54

0.12

Debt-equity ratio

-

1.03

Return on equity ratio

-3.20%

-14.34%

Trade receivables turnover ratio

-

1.41

Net capital turnover ratio

-

0.010

Net profit ratio

-65.30

-1343.13

Return on capital employed

4.13

-5.81

Operating Profit Margin

-

-1365.38%

Here is a summary of the financial and operational metrics for New Era Alkaloids & Exports Limited

Current Ratio

A current ratio below 1 indicates liquidity stress. Though it improved from 0.12 to 0.54 in FY 2024, the company still lacks sufficient current assets to cover its current liabilities, raising concerns about short-term solvency.

Debt-Equity Ratio

In FY 2023, the company had a moderately leveraged position. The absence of the ratio in FY 2024 may indicate that either debt or equity became negative or negligible, reflecting capital structure instability.

Return on Equity

Negative ROE in both years suggests the company incurred losses. However, the improvement in FY 2024 shows reduced losses and a slight move towards recovery.

Trade Receivables Turnover Ratio

A ratio of 1.41 in FY 2023 indicates slow collection. The missing value in FY 2024 could mean no significant sales or data inconsistency, impacting cash flow predictability.

Net Capital Turnover Ratio

An extremely low value in FY 2023 reflects poor utilization of capital. The absence of the ratio in FY 2024 might indicate negative working capital or minimal operations..

Net Profit Ratio

Both years show net losses, but FY 2024’s figure shows substantial improvement. However, a -65.30% margin still signals inefficiency and high costs relative to income.

Return on Capital Employed

A positive ROCE in FY 2024 suggests the company is starting to generate returns from its capital, a significant recovery from negative returns in FY 2023.

Operating Profit Margin

New Era Alkaloids & Export Annual Report

New Era Alkaloids And Exports Limited Annual Report 2023-2024

Download

New Era Alkaloids And Exports Limited Annual Report 2022-2023

Download

New Era Alkaloids And Exports Limited Annual Report 2021-2022

Download
Support Puja Support Ishika Support Purvi

News Alert